Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
- 8 January 2021
- journal article
- Published by Centers for Disease Control MMWR Office in MMWR. Recommendations and Reports
- Vol. 70 (1), 1-12
- https://doi.org/10.15585/mmwr.rr.7001a1
Abstract
Summary of the Advisory Committee on Immunization Practices’ recommendations for use of Ebola vaccine in the United States.Keywords
This publication has 56 references indexed in Scilit:
- Ebola virus diseaseThe Lancet, 2019
- The evolution of supportive care for Ebola virus diseaseThe Lancet, 2019
- Evidence-based guidelines for supportive care of patients with Ebola virus diseaseThe Lancet, 2017
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationEBioMedicine, 2017
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)The Lancet, 2016
- Late Ebola virus relapse causing meningoencephalitis: a case reportThe Lancet, 2016
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialThe Lancet Infectious Diseases, 2015
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialThe Lancet, 2015
- Ebola haemorrhagic feverThe Lancet, 2011
- Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques: Evidence that Dendritic Cells Are Early and Sustained Targets of InfectionThe American Journal of Pathology, 2003